Division News

The Duke Department of Medicine (DOM) is pleased to announce the Loan Repayment Program to Promote Diversity and Inclusion in Medicine (LRPDIM Award).

This award is part of a series of mentored career development opportunities offered by the DOM and is designed to fund underrepresented minorities in medicine who, as a group, are disproportionately impacted by student loans. This financial burden impedes retention, recruitment, and diversification of research faculty in the DOM.

The Department of Medicine (DOM) is creating a taskforce charged with developing the internal medicine component of a new program called outPatient Integrated lONgitudinal ExpERience, or PIONEER, for second-year medical students.

The goal of PIONEER is to increase their experience with the outpatient practice of general internal medicine and its subspecialties, as well as increase opportunities for faculty to teach medical students in the clinic setting.

The Duke University Internal Medicine program ranks No. 5 among 124 medical schools nationally in the 2023 U.S. News & World Report graduate program rankings released on March 30. The Duke University School of Medicine ranked No. 6 for research programs and many other departments at Duke were also ranked very highly.  

The Duke Internal Medicine Residency Program and the Duke Department of Medicine congratulate newly matched medical students who participated in the 2022 National Resident Matching Program.  We are especially excited to welcome our newest intern class! We cannot wait for you to join us here in Durham.

Gastroenterologist and researcher Jatin Roper, MD, has been awarded his first R01 grant from the National Cancer Institute of theNIH to identify mechanisms by which obesity-induced Wnt signaling promotes colorectal cancer progression.

Steve M. Taylor, MD, MPH, associate professor of medicine, Division of Infectious Diseases, and associate research professor of global health, is taking on the new position of Associate Vice Chair for Global Health Research in the Department of Medicine effective March 1, 2022.

Robert M. Califf, MD, Duke University adjunct professor of medicine (cardiology) and former director of the Duke Clinical Research Institute (DCRI), has been confirmed as commissioner for the U.S. Food and Drug Administration following a vote by the Senate today. Califf’s appointment to the position will mark his second time heading the agency, which he also led during the final year of former President Barack Obama’s administration.

Duke University School of Medicine was awarded more than $608 million in federal funding from the National Institutes of Health (NIH) in 2021, ranking third nationally among academic medical centers, up from 10th last year, according to the Blue Ridge Institute for Medical Research.

The Department of Medicine's award of that total was $174,530,472. 

Four School of Medicine faculty members have been selected to receive 2022 Physician-Scientist “Strong Start” awards. The awards program, funded with a gift from the Nanaline H. Duke Fund, supports promising, early career physician-scientists at Duke as they develop independent research programs.  

Sponsored Research

Andrew Armstrong of Medical Oncology has received an award from the Movember Foundation for a project entitled "International Retrospective Collaborative Analysis of the Impact of Ablative Therapy Directed to the Local Tumor and/or Metastases for Patients with Oligometastatic Prostate Cancer¿." TBD

Vance Fowler of Infectious Diseases has received an award from the National Institutes of Health for a project entitled "HLA Fine Mapping to Elucidate S. aureus Susceptibility - R01." Total funding will be $3,757,863.